Phibro Animal Health | PAHC - Sales Revenues


Phibro Animal Health reported $373.91M in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Align Technology USD 1.06B 20M Jun/2026
ANI Pharmaceuticals USD 266M 28.5M Jun/2026
Aurora Cannabis CAD 38.01M 56.18M Mar/2026
Bristol-Myers Squibb USD 12.97B 1.48B Jun/2026
Canopy Growth CAD 71.25M 3.29M Mar/2026
Corcept Therapeutics USD 256.15M 91.25M Jun/2026
Eli Lilly USD 22.97B 3.17B Jun/2026
Henry Schein USD 3.46B 90M Jun/2026
Idexx Laboratories USD 1.22B 80M Jun/2026
Knight Therapeutics CAD 133.11M 11.56M Dec/2025
Merck USD 16.6B 310M Jun/2026
Nektar Therapeutics USD 10.86M 10.95M Mar/2026
Pacira USD 192.4M 15.4M Jun/2026
Phibro Animal Health USD 373.91M 10.02M Dec/2025
Prestige Brands USD 265.71M 15.91M Jun/2026
Supernus Pharmaceuticals USD 219.1M 11.39M Jun/2026
Zoetis USD 2.5B 200M Jun/2026